Pitt's General Internal Medicine fellowship applications are open for July 2027 start. Deadline Sept 10. Clinician-Researcher Fellowship: dom.pitt.edu/dgim/fellows... ACES Fellowship: dom.pitt.edu/dgim/fellows...

Oregon Medicaid's 2016 policy capping benzodiazepine scripts at 4 weeks was linked to a substantial drop in long-term use and modest declines in overdose, self-harm, and withdrawal events. Work from Hartung's time as CP3 Visiting Scholar, with CP3's Anderson & Park. www.ovid.com/jnls/lww-med...

New @jamainternalmed.com study: 54% of new heart failure medication prescriptions went unfilled within 7 days of discharge, and only 42% of patients were adherent at 6 months. Coauthored by CP3's Tim Anderson. jamanetwork.com/journals/jam... #HeartFailure #GDMT

New JAMA Network Open research (with CP3's Anderson) finds Medicare drug-waste spending dropped to 1.8% before the 2021 refund policy even took effect, then held flat, still costing ~$1B/year by 2023. Refund rules may be maxed out. jamanetwork.com/journals/jam...

New in Medical Care: Patience Dow (former CP3 postdoc) & Julie Donohue (CP3 faculty) find Medicaid prescription caps linked to 12% higher risk of treatment gaps for opioid use disorder meds across 37 states. Caps may undermine treatment continuity. www.ovid.com/jnls/lww-med... #HealthPolicy

Congratulations to our faculty and friends in the University of Pittsburgh School of Pharmacy for receiving the Lawrence C. Weaver Transformative Community Service Award from the American Association of Colleges of Pharmacy (AACP)! www.pittwire.pitt.edu/accolades-ho...

Pitt’s School of Pharmacy received a national community service award

The school was honored at the American Association of Colleges of Pharmacy for its commitment to addressing unmet community needs through education, practice and research.

pittwire.pitt.edu

CP3's Tim Anderson, in JAMA today: 87.5M U.S. adults now recommended for statins under new guidelines — 21.5M more than before. A sea change for how doctors counsel patients on CV risk. www.upmc.com/media/news/0...

Over Half of U.S. Adults Eligible for Statins Under New Guidelines

Recommendations for cholesterol-lowering therapy expand by 21.5 million people

upmc.com

Congrats to CP3's Lucas Berenbrok & collaborator Elaine Mormer on their R13 grant from NIDCD to host the 2nd OTC Hearing Aid & Hearing Self-Care Symposium at Pitt — building on a decade of collaboration!

CP3's Tim Anderson weighs in on the FDA's approval of Lipfendra, the first oral PCSK9 inhibitor, a new "tool in the toolbox" for patients who can't tolerate statins. triblive.com/news/health-...

New cholesterol drug could ‘transform treatment’ — but statins aren’t going anywhere, doctors say

Pittsburgh doctors on Thursday hailed government approval of a highly effective anti-cholesterol pill that had previously been available only as an injection, but they cautioned that cheap, traditiona...

triblive.com

🎉 New funding! BUP-CARE, led by University of Florida with Jenny Lo-Ciganic heading Pitt's CP3 team, will use ML & EHR data to predict buprenorphine discontinuation risk, helping PCPs intervene early for patients with opioid use disorder. NIDA funded. cp3.pitt.edu/BUP-CARE

Developing and Evaluating a Machine-Learning Buprenorphine Care Discontinuity Prediction E-Tool (BUP-CARE)

Learn about BUP-CARE, a research study at the University of Pittsburgh's Center for Pharmaceutical Policy and Prescribing (CP3). BUP-CARE uses machine learning within electronic health records to pred...

cp3.pitt.edu

New study in The Lancet: older adults with obesity now have BP & cholesterol near normal-weight levels, thanks to more meds. Under-40s with obesity still face higher heart risks. STAT talked to CP3's Tim Anderson: www.statnews.com/2026/07/01/l...

Statins and blood pressure drugs changing health risks of obesity, study suggests

New research shows obesity patients over 40 are managing blood pressure and cholesterol as well as healthy-weight peers, but younger adults remain at risk.

statnews.com

CP3's Jing Luo led the first RCT comparing glargine vs. human insulin for youth with type 1 diabetes in low-resource settings. Key finding: no significant difference. 🌍 www.sciencedirect.com/science/arti...

CP3's Drs. Donohue, Gellad & Lo-Ciganic joined NIDA experts to explore target trial emulation & digital health tools for SUD research. Read the proceedings here: www.jsatjournal.com/article/S294...

New CP3 analysis (Drake & Donohue) found greater methadone/naltrexone availability raised use among White Medicaid enrollees, but not Black or Hispanic enrollees. 🔍 Access alone won't close OUD treatment gaps. More: jamanetwork.com/journals/jam... @jamahealthforum.com

Our latest newsletter is live! We've got conference recaps, speaker highlights, a new machine learning prediction grant, new papers, and more! createsend.com/t/j-1B759B6E...

In this analysis, there were language-based disparities in orders for physical restraints & antipsychotics among hospitalized patients. More investigation is needed to explain and mitigate these differences. Read more @journalgim.bsky.social: link.springer.com/article/10.1...

🆕analysis of dental claims found 1 adverse outcome for every 27 pediatric dental sedation visits, highlighting the need for improved risk mitigation to improve safety in young dental patients. Read more: jada.ada.org/article/S000...

For adults with diabetes, the inclusion of HbA1c & UACR in the PREVENT equations is an opportunity to individualize their CVD risk estimation. Read more: www.ajpmonline.org/article/S074...

We've joined LinkedIn! Follow us for more in-depth updates on our papers, presentations, and announcements. www.linkedin.com/company/pitt...

Center for Pharmaceutical Policy and Prescribing | LinkedIn

Center for Pharmaceutical Policy and Prescribing | 31 followers on LinkedIn. Center for Pharmaceutical Policy and Prescribing (CP3) at the University of Pittsburgh. | The Center for Pharmaceutical Pol...

linkedin.com

We've learned a lot in our ten years of designing & implementing risk prediction models! We're looking forward to traveling to #cpdd26 to join our friends from @brownpublichealth.bsky.social to share what we've learned! @cpddorg.bsky.social

Findings from this analysis suggest that supply chain issues alone don't translate into a shortage, highlighting a need for a better system to identify true shortages that affect patients’ ability to access medications. Read more @jamanetworkopen.com jamanetwork.com/journals/jam...

Our machine learning maven Dr. Jenny Lo-Ciganic has done it again! This time, she was part of a team that improved prediction of hepatitis C infection using natural language processing of social determinants of health-related clinical notes. www.journal-of-hepatology.eu/article/S016...

Raising the ferritin cutoff to diagnose iron deficiency anemia sounds helpful, but who does it actually catch? Mostly premenopausal women who need dietary iron, not GI workups. New data from Drs. Anderson & Vajravelu: onlinelibrary.wiley.com/doi/10.1002/...

In this analysis, baseline HTN didn't influence initial analgesic choice in incident OA patients. Safer, evidence-based alternatives are needed for older adults with comorbid HTN. Read more: agsjournals.onlinelibrary.wiley.com/doi/10.1111/...

With so many EHR interventions lately, alert fatigue is an important metric to consider. However, measurement methods aren't clearly or consistently defined, according to a 🆕review. Read more: academic.oup.com/jamia/advanc...

In this analysis of VHA data, 8.5% of users of a group of 29 different medications experienced disruptions related to the shortage. Ophthalmic and antipsychotic agents were more likely to experience disruption. Read more: onlinelibrary.wiley.com/doi/10.1002/...

🚨Job alert!🚨 Pitt Pharmacy is hiring a tenure track position for a Professor of Pharmacogenomics/Precision Medicine. Be part of a highly productive, highly collaborative environment! More: cfopitt.taleo.net/careersectio...

CP3 alum Dr. Patience Dow led this paper suggesting that state Medicaid prescription caps were associated with lower overall use of prescription medications and more frequent acute care use. CP3 faculty Dr. Julie Donohue co-authored. Read more @jamahealthforum.com jamanetwork.com/journals/jam...

In this commentary, CP3's Dr. Tim Anderson & co-authors describe new dyslipidemia management guidelines and how they emphasize shared decision making and avoid inflexible age-based thresholds. www.jacc.org/doi/10.1016/...

Our Dr. Jenny Lo-Ciganic talked with ACCP Journals Podcast about her #machinelearning work to predict falls among older adults with depression. Tune in! podcasts.apple.com/us/podcast/p...

Predicting Fall Risks in Older Adults with Depression: A Machine Learning Approach - Ep 183

Podcast Episode · ACCP JOURNALS · May 19 · 30m

podcasts.apple.com